Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar 1;90(5):1756-60.
doi: 10.1073/pnas.90.5.1756.

Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice

Affiliations

Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice

M Adachi et al. Proc Natl Acad Sci U S A. .

Abstract

The mouse lpr (lymphoproliferation) mutation carries a rearrangement in the chromosomal gene for the Fas antigen, which mediates apoptosis. Isolation and characterization of mouse Fas antigen chromosomal gene from wild-type and lpr mice indicated an insertion of an early transposable element (ETn) in intron 2 of the Fas antigen gene of lpr mice. Hybrid transcripts carrying the Fas antigen and ETn sequences were expressed in the thymus and liver of the mutant. This indicated that premature termination and aberrant splicing of the Fas antigen transcript caused by the insertion of the ETn in the intron are responsible for the lymphoproliferation and autoimmune phenotype of the mutant mouse. On the other hand, an insertion of the ETn into an intron of a mammalian expression vector dramatically but not completely reduced the expression efficiency. These findings suggest that lpr mice are able to express a very low level of the Fas antigen.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1988 Dec 1;168(6):2221-9 - PubMed
    1. J Immunol. 1991 Jul 15;147(2):466-74 - PubMed
    1. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5641-5 - PubMed
    1. J Immunol. 1984 Jul;133(1):227-33 - PubMed
    1. EMBO J. 1986 Mar;5(3):575-81 - PubMed

Publication types